Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1038/s41467-026-71102-x

Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial

Rebecca L. Porter & Panagiotis A. Konstantinopoulos et al. · 2026

Links

DOI

Journal

Unknown Journal

Authors

Rebecca L. Porter, Yinglu Zhou, Nebiyat Eskndir, Martin Hayes, Madeline Polak, Elizabeth K. Lee, Carolyn Krasner, Susana Campos, Alexi A. Wright, Joyce F. Liu, Elizabeth H. Stover, Hannah Sawyer, Niya Xiong, Kathleen L. Pfaff, Scott J. Rodig, Nabihah Tayob, Susan Zweizig, Veena John, Jennifer Veneris, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos